Eligibility Parkinson's Disease NCT00208611

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients seen in emory healthcare system at least once between 1/1/2002 and 05/31/2006 with idiopathic parkinson's disease (defined as):
Beschreibung

Patients with idiopathic parkinson's disease who are seen regulary

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0747270
UMLS CUI [1,2]
C0205272
UMLS CUI [1,3]
C0545082
>2 of cardinal signs/symptoms of parkinson's disease (bradykinesia, tremor, rigidity)
Beschreibung

Bradykinesia, tremor, rigidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0233565
UMLS CUI [2]
C0040822
UMLS CUI [3]
C0026837
>50% improvement of symptoms when dopaminergic therapy started
Beschreibung

Improvement on dopaminergic therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2986411
UMLS CUI [1,2]
C3267134
cohabiting spousal caregivers (without parkinson's disease) of patients enrolled in study are also eligible (but not required) to participate
Beschreibung

Spousal without parkinson's disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0682323
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C0747270
coexisting depression, if present, is stable
Beschreibung

Depression

Datentyp

boolean

Alias
UMLS CUI [1]
C0011581
normal thyroid screen (done at screening visit or at emory healthcare system within 3 months of screening visit)
Beschreibung

Thyroid Screen

Datentyp

boolean

Alias
UMLS CUI [1]
C0740212
males must have normal fasting testosterone levels (done at screening visit or within 6 months of screening visit)
Beschreibung

Fasting testosterone levels

Datentyp

boolean

Alias
UMLS CUI [1]
C0202227
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
unstable medical conditions (terminal cancer, angina, etc) which could interfere with study assessments or put patient at risk for not completing the assessments.
Beschreibung

Comorbidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
dopaminergic-unresponsive parkinsonism (i.e., patient has suspected multiple systems atrophy (msa), vascular or another form of parkinsonism)
Beschreibung

Dopaminergic-unresponsive parkinsonism

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3844724
UMLS CUI [1,2]
C3267134
UMLS CUI [1,3]
C0242422
prior history of vitamin b12 deficiency or taking vitamin b12 supplements or injections (single multivitamin supplements are not an exclusion criteria)
Beschreibung

Vitamin b12 deficiency vitamin b12 supplement therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0042847
UMLS CUI [2]
C3661586
untreated testosterone or thyroid abnormality
Beschreibung

Testosterone or thyroid abnormality

Datentyp

boolean

Alias
UMLS CUI [1]
C1540745
UMLS CUI [2]
C0040128

Ähnliche Modelle

Eligibility Parkinson's Disease NCT00208611

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Patients with idiopathic parkinson's disease who are seen regulary
Item
patients seen in emory healthcare system at least once between 1/1/2002 and 05/31/2006 with idiopathic parkinson's disease (defined as):
boolean
C0747270 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0545082 (UMLS CUI [1,3])
Bradykinesia, tremor, rigidity
Item
>2 of cardinal signs/symptoms of parkinson's disease (bradykinesia, tremor, rigidity)
boolean
C0233565 (UMLS CUI [1])
C0040822 (UMLS CUI [2])
C0026837 (UMLS CUI [3])
Improvement on dopaminergic therapy
Item
>50% improvement of symptoms when dopaminergic therapy started
boolean
C2986411 (UMLS CUI [1,1])
C3267134 (UMLS CUI [1,2])
Spousal without parkinson's disease
Item
cohabiting spousal caregivers (without parkinson's disease) of patients enrolled in study are also eligible (but not required) to participate
boolean
C0682323 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0747270 (UMLS CUI [1,3])
Depression
Item
coexisting depression, if present, is stable
boolean
C0011581 (UMLS CUI [1])
Thyroid Screen
Item
normal thyroid screen (done at screening visit or at emory healthcare system within 3 months of screening visit)
boolean
C0740212 (UMLS CUI [1])
Fasting testosterone levels
Item
males must have normal fasting testosterone levels (done at screening visit or within 6 months of screening visit)
boolean
C0202227 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Comorbidity
Item
unstable medical conditions (terminal cancer, angina, etc) which could interfere with study assessments or put patient at risk for not completing the assessments.
boolean
C0009488 (UMLS CUI [1])
Dopaminergic-unresponsive parkinsonism
Item
dopaminergic-unresponsive parkinsonism (i.e., patient has suspected multiple systems atrophy (msa), vascular or another form of parkinsonism)
boolean
C3844724 (UMLS CUI [1,1])
C3267134 (UMLS CUI [1,2])
C0242422 (UMLS CUI [1,3])
Vitamin b12 deficiency vitamin b12 supplement therapy
Item
prior history of vitamin b12 deficiency or taking vitamin b12 supplements or injections (single multivitamin supplements are not an exclusion criteria)
boolean
C0042847 (UMLS CUI [1])
C3661586 (UMLS CUI [2])
Testosterone or thyroid abnormality
Item
untreated testosterone or thyroid abnormality
boolean
C1540745 (UMLS CUI [1])
C0040128 (UMLS CUI [2])